Pharmacokinetics and tissue distribution of eupatilin and its metabolite in rats by an HPLC-MS/MS method
- 1 September 2018
- journal article
- research article
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 159, 113-118
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81573553)
This publication has 13 references indexed in Scilit:
- Eupatilin, a Major Flavonoid of Artemisia, Attenuates Aortic Smooth Muscle Cell Proliferation and Migration by Inhibiting PI3K, MKK3/6, and MKK4 ActivitiesPlanta Medica, 2013
- Inhibitory effects of eupatilin on tumor invasion of human gastric cancer MKN-1 cellsTumor Biology, 2013
- The neuroprotective effect of eupatilin against ischemia/reperfusion-induced delayed neuronal damage in miceEuropean Journal of Pharmacology, 2012
- Eupatilin inhibits lipopolysaccharide-induced expression of inflammatory mediators in macrophagesLife Sciences, 2011
- Inhibitory effect of eupatilin and jaceosidin isolated from Artemisia princeps on carrageenan-induced inflammation in miceJournal of Ethnopharmacology, 2009
- Eupatilin inhibits T‐cell activation by modulation of intracellular calcium flux and NF‐κB and NF‐AT activityJournal of Cellular Biochemistry, 2009
- Eupatilin exhibits a novel anti-tumor activity through the induction of cell cycle arrest and differentiation of gastric carcinoma AGS cellsDifferentiation, 2009
- Eupatilin inhibits H2O2-induced apoptotic cell death through inhibition of mitogen-activated protein kinases and nuclear factor-κBFood and Chemical Toxicology, 2008
- Eupatilin Protects Gastric Epithelial Cells from Oxidative Damage and Down-Regulates Genes Responsible for the Cellular Oxidative StressPharmaceutical Research, 2008
- Eupatilin attenuates bile acid-induced hepatocyte apoptosisJournal of Gastroenterology, 2006